NanoRepro AG (ETR:NN6)
Germany · Delayed Price · Currency is EUR 1.415
-0.035 (-2.41%)
Apr 10, 2026, 5:35 PM CET
NanoRepro AG Market Cap
NanoRepro AG has a market cap or net worth of €17.85 million as of April 10, 2026. Its market cap has decreased by -2.08% in one year.
Market Cap
17.85M
Enterprise Value
10.56M
Revenue
5.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.42
Market Cap Chart
Since October 10, 2008, NanoRepro AG's market cap has increased from 12.43M to 17.85M, an increase of 43.62%. That is a compound annual growth rate of 2.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 17.85M | -5.98% |
| Dec 30, 2025 | 18.98M | 7.89% |
| Dec 30, 2024 | 17.60M | -31.51% |
| Dec 29, 2023 | 25.69M | -9.71% |
| Dec 30, 2022 | 28.45M | -70.56% |
| Dec 30, 2021 | 96.65M | 175.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 48.63B |
| Siemens Healthineers AG | 42.14B |
| Bayer Aktiengesellschaft | 39.41B |
| Fresenius SE & Co. KGaA | 25.18B |
| Cantourage Group SE | 58.86M |
| Pentixapharm Holding AG | 48.45M |
| MeVis Medical Solutions AG | 41.86M |
| Maternus-Kliniken Aktiengesellschaft | 23.91M |